These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 16872316

  • 1. Expression of cyclo-oxygenase-2 in gastrointestinal carcinoid tumors.
    Mizuno S, Kato K, Hashimoto A, Sugitani M, Sheikh A, Komuro S, Jike T, Iwasaki A, Arakawa Y, Nemoto N.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1313-9. PubMed ID: 16872316
    [Abstract] [Full Text] [Related]

  • 2. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M, Wu TT, Wallace C, Houlihan PS, Hamilton SR, Rashid A.
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
    Jirásek T, Hozák P, Mandys V.
    Neoplasma; 2003 Dec; 50(1):1-7. PubMed ID: 12687271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An evaluation of cyclooxygenase-2 as a prognostic biomarker in mid-gut carcinoid tumours.
    Cadden I, Johnston BT, Turner G, McCance D, Ardill J, McGinty A.
    Neuroendocrinology; 2007 Dec; 86(2):104-11. PubMed ID: 17700013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C.
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [Abstract] [Full Text] [Related]

  • 13. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.
    Miettinen M, Lehto VP, Dahl D, Virtanen I.
    Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121
    [Abstract] [Full Text] [Related]

  • 14. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
    Long KB, Srivastava A, Hirsch MS, Hornick JL.
    Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
    [Abstract] [Full Text] [Related]

  • 15. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Bergmann F, Breinig M, Höpfner M, Rieker RJ, Fischer L, Köhler C, Esposito I, Kleeff J, Herpel E, Ehemann V, Friess H, Schirmacher P, Kern MA.
    Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
    [Abstract] [Full Text] [Related]

  • 16. Tryptophan hydroxylase and 5-hydroxytryptamine in carcinoids of the gastrointestinal tract.
    Brinck U, Meyer T.
    Anticancer Res; 2000 Jan; 20(4):2325-8. PubMed ID: 10953292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract.
    Konturek PC, Kania J, Burnat G, Hahn EG, Konturek SJ.
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():57-73. PubMed ID: 16247189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.